https://www.prognyx.com/2026-06-15weekly0.9 https://www.prognyx.com/blog/2026-06-15weekly0.9 https://www.prognyx.com/blog/spectrum-terminates-its-648-patient-poziotinib-exon-20-phase-2-a-business-call-n2026-06-15weekly0.8